Hi Pivalde,Thankyou once again for your informative input, it is...

First 21 Last

Share
Profile

Follow
Scottsmyname

402 Posts.

27

19/04/24

01:18

Post #: 73416671
Share

Originally posted by pivalde: ↑

In the orphan drug meeting in Boston Dr. Pall will talk about "Biophysical Characteristics of ATH434, a Unique Iron-Targeting Drug for Treating
Friedreich’s Ataxia".
I would think that the presentation is mostly about biophysical characteristics and not yet anything related that it would be tested in FA patients, but perhaps in the FA cells of these patients.
It is an important study also regarding other degenerative diseases but at this phase "not price sensitive".

It is not evident that ATH will give any "price sensitive" announcements in any scientific meeting. IMO the open study results will be announced as separate announcements. The first open-study patient was recruited 11 months ago but it took until February to get all 15 patients (?). So it is impossible to get all the results before the randomized study which ends in November. IMO, we will get the 6-month results in June but only for the first 10 (?)patients. This would be enough to see the trend if ATH434 works in these patients. There will be an MRI scan after 6 months. So, we get an answer if ATH434 reduces iron content in the brain as in experimental MSA and PD studies. Iron content is the "primary outcome measure" in both studies, so I think this is what we are waiting for.

They already have the collected blood and spinal fluid analyses as well as questionnaire results from many patients but when the primary outcome measure is still missing, they wait before they can be sure that the trend is seen. ATH434 is a "Unique Iron-Targeting drug" with special biophysical characteristics as Dr. Pall will tell us next week.

Expand

Hi Pivalde,

Thankyou once again for your informative input, it is valued information and IMO.

I agree with your statement, but reading the poster information it was very positive, one can only increase confidence in this study.

But time will tell when this.rocket takes off or aborts. I feel all engines are on running mode, awaiting for take of mode.

But us holders are buckled in ready for blast off, and reading all info

ATH Price at posting: 0.5¢ Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

There are more pages in this discussion • 2 more messages in this thread...

First 21 Last

Add ATH (ASX) to my watchlist

(20min delay)
Last 0.5¢		Change 0.001(25.0%)		Mkt cap ! $26.22M

Open	High	Low	Value	Volume
0.5¢	0.5¢	0.5¢	$10.54K	2.185M

Buyers (Bids)

No.	Vol.	Price($)
59	83226460	0.4¢

Sellers (Offers)

Price($)	Vol.	No.
0.5¢	20297608	17

View Market Depth

No.	Vol.	Price($)
1	2000	0.005
59	83773711	0.004
50	54685564	0.003
16	38993014	0.002
12	93270101	0.001

Price($)	Vol.	No.
0.005	29747620	20
0.006	35627345	23
0.007	14674670	16
0.008	14085875	15
0.009	6171000	7

Last trade - 10.13am 10/06/2024 (20 minute delay)

ATH (ASX) Chart

Hi Pivalde,Thankyou once again for your informative input, it is...

Featured News

Conference preview: Sprott founder Rick Rule shares his secrets to investing in commodities

Westgold sees Starlight mineral resource jump 41%

The Big Deal: All the latest in business & sport

Seek and ye shall reap reward is this week's maxim

Money and Investing: Fixing financial mistakes in your 30s and 40s

Buyers (Bids)

Sellers (Offers)

Featured News

Hi Pivalde,Thankyou once again for your informative input, it is...

Featured News

Top Stories

Conference preview: Sprott founder Rick Rule shares his secrets to investing in commodities

Westgold sees Starlight mineral resource jump 41%

The Big Deal: All the latest in business & sport

Seek and ye shall reap reward is this week's maxim

Money and Investing: Fixing financial mistakes in your 30s and 40s

Buyers (Bids)

Sellers (Offers)

Featured News